Chemesis International Inc. to Construct GMP Certified Extraction Facility & Production Lab in Bogota, Colombia
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. to Construct GMP Certified Extraction Facility & Production Lab in
Bogota, Colombia
Colombia based, La Finca Interacviva-Arachna Med announces plans to construct Certified Extraction Facility &
Production Lab with International Export Capabilities
January 28, 2019
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), announces its wholly o wned subsidiary La Finca Interacviva -Arachna Med (“La Finca”)
plans to commence construction of its GMP certified extraction facility before the end of Q1, 2019. The
state-of-the-art facility will also house a certified production lab, which will have a large production
capacity for both domestic and international markets.
Chemesis has a strong track record of constructing and operating compliant extraction labs in different
international markets, as demonstrated in California and Puerto Rico. The Company will leverage a f irst
mover advantage in Colombia, where there is currently a scarcity of certified extraction facilities. La
Finca will continue to add to its current 1,060 acre cultivation land as construction begins on the new
processing facility.
The Company is also p leased to announce, La Finca has been granted a Seed Producer License. La Finca
recently had a verification visit from ICA (Colombian Ministry of Agriculture), where La Finca
demonstrated full compliance with all regulations and infrastructure requirements to be granted this
license. As per ICA regulations, La Finca will work towards the completion of additional agronomic
evaluations. Once completed, the Company will be permitted to commence large scale commercial
cultivation in regions across the nation.
As previously announced, the Company and Universidad Nacional of Colombia will continue their
partnership to research ideal densities for biomass , yield improvement, ideal seed strains per climate,
and harvesting techniques. In addition, the Company and University are researching indoor cultivation
for high content CBD flower. This initial research, cultivation, and harvesting will occur in La Finc a’s
10,000 ft2 greenhouse.
“We are extremely pleased with La Finca and the progress it has made in such a short period of time,”
said CEO, Edgar Montero. “The Company’s certified extraction facility will allow the Company to service
both domestic and international markets with a variety of finished goods, for its in house and third-party
brands.”
Additional updates on Colombia operations and construction will be provided in the near future
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently
operating within California, Puerto Rico, and Colombia.
Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution
and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective
production and distribution of its products. In addition, Chemesis leverages exclusive brands and
partnerships and uses the highest quality extraction methods to provide consumers with quality
cannabis products.
Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently
delivering quality product to its consumers from seed to sale.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
CaliforniaSap.instagram
Jay&SB.instagram
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of
applicable securities laws relating to statements regarding the Company's business, products and future of the
Company’s business, its product offerings and plans for sales and marketing, includi ng finalizing an acquisition in
Colombia. Although the Company believes that the expectations reflected in the forward -looking information are
reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to
place undue reliance on forward -looking information. Such forward -looking statements are subject to risks and
uncertainties that may cause actual results, performance and developments to differ materially from those
contemplated by these statements depe nding on, among other things, the risks that the Company's products and
plan will vary from those stated in this news release and the Company may not be able to carry out its business
plans as expected. Except as required by law, the Company expressly disc laims any obligation and does not intend
to update any forward -looking statements or forward -looking information in this news release. Although the
Company believes that the expectations reflected in the forward -looking information are reasonable, there ca n be
no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales
reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release